Washington State University Health Sciences and Seattle Children’s Research Institute awarded six collaborative projects $300,000 in seed grant funding, following an inaugural joint symposium between the two institutions this fall at WSU Spokane.
The funding will support the development of solutions for infant neurodevelopmental care, nanotechnology-based therapies for tuberculosis, and a nanomaterial-based biosensor for pediatric TB screening, as well as research on substance use in young chronic pain patients, non-invasive biomarkers for juvenile idiopathic arthritis, and obesity-related asthma. “Bringing together two of our state’s leading health research institutions creates pivotal opportunities now and in the future for expanding the breadth and impact of our collective research missions,” said Daryll DeWald, executive vice president of WSU Health Sciences.
This partnership further highlights Washington state’s robust life science collaboration, driving innovation on a national scale.